Israel - hebraico - Ministry of Health

trupharm marketing 1985 ltd. - dithranol 0.25 %w/w - cream - dithranol - topical treatment of sub-acute & chronic psoriasis,including psoriasis of the scalp.

Israel - hebraico - Ministry of Health

trupharm marketing 1985 ltd. - dithranol 1 %w/w - cream - dithranol - topical treatment of sub-acute & chronic psoriasis,including psoriasis of the sculp.

Israel - hebraico - Ministry of Health

trupharm marketing 1985 ltd. - dithranol 0.5 %w/w - cream - dithranol - topical treatment of sub-acute & chronic psoriasis,including psoriasis of the scalp.

Israel - hebraico - Ministry of Health

trupharm marketing 1985 ltd. - dithranol 2 %w/w - cream - dithranol - topical treatment of subacute and chronic psoriasis including psoriasis of the scalp.

Israel - hebraico - Ministry of Health

abic marketing ltd, israel - acitretin - קפסולות - acitretin 10 mg - acitretin - acitretin - severe disorders of keratinization such as erythrodermic psoriasis local or generalized pustular psoriasis congenital ichthyosis pityriasis rubra pilaris darier's disease.

Israel - hebraico - Ministry of Health

trima israel pharmaceutical products maabarot ltd - betamethasone as valerate - תמיסה - betamethasone as valerate 0.1 %w/w - betamethasone - betamethasone - a specific treatment for dermatoses of the scalp.

Israel - hebraico - Ministry of Health

dexcel ltd - betamethasone as dipropionate 0.5 mg / 1 g; calcipotriol as hydrate 50 mcg / 1 g - gel - betamethasone - topical treatment of psoriasis vulgaris on the scalp and topical treatment of mild to moderate “non-scalp” plaque psoriasis vulgaris in adults 18 years of age and older.

Israel - hebraico - Ministry of Health

padagis israel agencies ltd, israel - mercaptopurine - טבליה - mercaptopurine 50 mg - mercaptopurine - mercaptopurine - for the treatment of acute leukemia and also in cases of chronic myelogenous leukemia.

Israel - hebraico - Ministry of Health

j-c health care ltd - golimumab - תמיסה להזרקה - golimumab 50 mg / 0.5 ml - golimumab - golimumab - rheumatoid arthritis :simponi, in combination with methotrexate, is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis when the response to disease-modifying anti-rheumatic drug (dmard) therapy including mtx has been inadequate.psoriatic arthritis :simponi, alone or in combination with methotrexate, is indicated for the treatment of adult patients with active and progressive psoriatic arthritis when the response to previous disease-modifying anti-rheumatic drug (dmard) therapy has been inadequate.ankylosing spondylitis :simponi is indicated for the treatment of adult patients with severe active ankylosing spondylitis who have responded inadequately to conventional therapy.

Israel - hebraico - Ministry of Health

abbvie biopharmaceuticals ltd, israel - upadacitinib as hemihydrate - טבליות בשחרור ממושך - upadacitinib as hemihydrate 15 mg - upadacitinib